SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001802768-22-000035
Filing Date
2022-08-04
Accepted
2022-08-04 09:10:46
Documents
75
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q rprx-20220630.htm   iXBRL 10-Q 2976684
2 EX-31.1 rprx-20220630ex311.htm EX-31.1 9357
3 EX-31.2 rprx-20220630ex312.htm EX-31.2 9393
4 EX-32 rprx-20220630ex32.htm EX-32 5113
  Complete submission text file 0001802768-22-000035.txt   11454653

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rprx-20220630.xsd EX-101.SCH 68172
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rprx-20220630_cal.xml EX-101.CAL 92696
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rprx-20220630_def.xml EX-101.DEF 400282
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rprx-20220630_lab.xml EX-101.LAB 710933
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rprx-20220630_pre.xml EX-101.PRE 500216
69 EXTRACTED XBRL INSTANCE DOCUMENT rprx-20220630_htm.xml XML 2396993
Mailing Address 110 EAST 59TH STREET NEW YORK NY 10022
Business Address 110 EAST 59TH STREET NEW YORK NY 10022 (212) 883-0200
Royalty Pharma plc (Filer) CIK: 0001802768 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39329 | Film No.: 221134967
SIC: 2834 Pharmaceutical Preparations